In contrast to the heterogeneous effects of HDACs on Treg cell populations, studies investigating Treg-mediated tumor immunosuppression observed a significant increase in EZH2 expression, specifically in tumor-infiltrating Treg cells [128]. The gene discussed is EZH2; the disease is neoplasm.